The authors explored data from more than 800 patients with coronary heart disease, sharing their findings in Plos Medicine.

There are no benefits to treating patients with hydroxychloroquine after they have already been exposed to COVID-19, according to a new study published in the New England Journal of Medicine.

The authors emphasized the importance of investing in "substance use treatment, harm reduction, and structural drivers of overdose" as the pandemic continues. 

Women were also seen less regularly by a cardiovascular specialist.

Specialists also believe that private insurers will follow Medicare's example and reduce their own reimbursement rates.

Cheryl Pegus, MD, is a veteran cardiologist with prior experience at such companies as Aetna, Pfizer and Cambia Health Solutions.

A large coalition, including several cardiology groups, is asking Congress to pass legislation that would help protect healthcare providers from the final rule's "arbitrary" Medicare cuts. 

From finding middle ground with prospective employers to understanding enforceability and exit strategies, here are practical approaches for reducing risks.

Clinical and administrative leaders are employing creative, out-of-the-box thinking to engage, enrich, nurture and distract staff who are facing unprecedented challenges and risks.

People tend to perceive themselves as less swayed than others by COVID-19 misinformation, and the gap helps explain why some people are more open than others to governmental interventions.

More than 105 exhibitors presented AI-specific wares in the virtual AI showcase. That was down from 2019’s pre-COVID 150 but still easily beat 2018’s head count, around 75.